ArticlePharmaceuticals (Basel, Switzerland)2026
7-Prenyloxycoumarins as Promising Antileishmanial Agents: In Vitro, In Vivo, and In Silico Evaluation Against
Dirlei Nico, Daniel Clemente de Moraes, Anna Claudia Silva, Igor Nunes Taveira, Yasmin da Silva Fontes, Rosangela Sabbatini Capella Lopes, Cláudio Cerqueira Lopes, Antonio Ferreira-Pereira
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Dirlei NicoDepartamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Daniel Clemente de MoraesDepartamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.
Anna Claudia SilvaLaboratório de Síntese e Análise de Produtos Estratégicos, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, RJ, Brazil.
Igor Nunes TaveiraDepartamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-170, RJ, Brazil.ORCID 0000-0002-9763-6763 Yasmin da Silva FontesDepartamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.ORCID 0000-0001-8938-9267 Rosangela Sabbatini Capella LopesLaboratório de Síntese e Análise de Produtos Estratégicos, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, RJ, Brazil.
Cláudio Cerqueira LopesLaboratório de Síntese e Análise de Produtos Estratégicos, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-909, RJ, Brazil.
Antonio Ferreira-PereiraDepartamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil.ORCID 0000-0002-0474-8388 Funding
National Council for Scientific and Technological Development- CNPq 302660/2023-2National Council for Scientific and Technological Development- CNPq 304648/2025-6Rio de Janeiro State Research Support Foundation- FAPERJ APQ1Rio de Janeiro State Research Support Foundation- FAPERJ E-26/010/100812/2018 - ADT 1Rio de Janeiro State Research Support Foundation- FAPERJ E-26/201.208/2021
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
altissimacoumarin DantileishmanialcoumarinsLeishmaniaspermidine synthase
Identifiers
PMID41901273
PMCPMC13029137
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390